Funding for this research was provided by:
Received: 10 June 2019
Accepted: 13 August 2019
First Online: 24 August 2019
Change Date: 27 November 2019
Change Type: Correction
Change Details: The article Reversal agents for oral anticoagulant-associated major or life-threatening bleeding, written by Marco Moia, Alessandro Squizzato was originally published electronically on the publisher���s internet portal (currently SpringerLink) on 24 August 2019 without open access.
Compliance with ethical standards
: Alessandro Squizzato received fees for lectures and advisory board meetings from Daiichi Sankyo, Pfizer, Bristol Myers Squibb, Bayer, Boehringer Ingelheim. Marco Moia received fees for lectures from Bayer, Daiichi Sankyo, Pfizer, Werfen.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study formal consent is not required.